Germany’s Evonik and Lanxess Face Continued Gloomy Analyst Outlooks

Introduction

Germany’s specialty chemicals industry continues to operate under challenging conditions, with Evonik and Lanxess facing persistent pressure from weak industrial demand, high operating costs, international competition, and geopolitical uncertainty.

Although there are signs of improvement in parts of the sector, analysts remain cautious about the pace and durability of any recovery. The situation reflects the broader difficulties facing Germany’s chemical industry, where companies are attempting to protect margins while dealing with excess global capacity and weaker European demand.

Evonik Shows Improvement, but Risks Remain

Evonik entered the second half of 2026 with a stronger operational position than earlier in the year. In June, the company raised its 2026 adjusted EBITDA outlook to €2.0 billion–€2.2 billion, following stronger-than-expected second-quarter performance. The company said it benefited partly from disruptions in global supply chains.

However, the improved guidance does not eliminate the structural challenges facing the company.

Evonik remains exposed to global industrial demand, raw-material costs, energy prices, and competition from producers in regions with lower production costs. Analysts therefore continue to question how sustainable the improvement will be once temporary supply disruptions fade.

Lanxess Remains Exposed to Weak Industrial Demand

Lanxess is facing a similar environment.

The company confirmed its 2026 adjusted EBITDA guidance at €450 million–€550 million in its first-quarter results. Management highlighted significant macroeconomic uncertainty, including the effects of the Middle East conflict, currency headwinds, and continued cost pressures.

Lanxess also expects Germany’s infrastructure program to provide support to construction-related end markets, although the positive effect was expected to emerge from the second half of 2026.

This means the company is depending partly on an improvement in European industrial activity to offset ongoing weakness elsewhere.

Weak Demand Remains a Central Problem

The most important issue for both companies is subdued demand.

Germany’s chemical industry has struggled with weak industrial activity for several years. Automotive, construction, manufacturing, and other major customer industries have faced slower growth, reducing demand for chemical intermediates and specialty products.

Lower demand can have an especially strong impact on chemical manufacturers because production facilities require high utilization rates to operate efficiently.

When plants operate below optimal capacity, fixed costs are spread over fewer products, putting additional pressure on margins.

Asian Competition Adds Further Pressure

Another major challenge is competition from Asia.

Chemical producers in China and other Asian markets have expanded capacity across numerous product categories. When domestic demand is insufficient to absorb this capacity, additional volumes can move into export markets.

European producers can consequently face lower-priced imports and greater pressure on selling prices.

The same competitive environment has been identified as a major challenge for Lanxess and other European specialty chemical companies, alongside subdued industrial demand and elevated energy costs.

For Evonik and Lanxess, maintaining competitiveness therefore requires more than simply waiting for demand to recover. Companies must also improve cost structures, optimize production networks, and focus on higher-value products.

Energy Costs Remain a Structural Disadvantage

Germany’s energy-cost disadvantage continues to weigh on chemical manufacturers.

Chemical production can be highly energy intensive, making electricity and natural-gas prices critical components of manufacturing economics.

European producers have faced a difficult combination of relatively high energy costs and increasing competition from regions with cheaper feedstocks and energy.

This issue has become particularly important for Germany, where the chemical industry is a major industrial consumer and an important part of the manufacturing ecosystem.

Geopolitical Risks Increase Uncertainty

Geopolitical developments are adding another layer of uncertainty.

Lanxess specifically highlighted the Middle East conflict as a factor intensifying macroeconomic uncertainty in its 2026 outlook.

For chemical companies, geopolitical disruptions can affect energy prices, raw-material availability, transportation costs, insurance, and international trade flows.

Interestingly, Evonik's stronger second-quarter performance was partly supported by disruptions in global supply chains. However, such benefits are difficult to treat as sustainable because they can disappear once supply conditions normalize.

Germany’s Infrastructure Spending Offers Some Hope

One potential positive factor is Germany’s planned infrastructure spending.

Lanxess expects the government's infrastructure program to support construction-related demand, although management indicated that the impact would emerge from the second half of 2026.

Stronger infrastructure investment could benefit chemicals used in construction materials, coatings, additives, insulation, and other industrial applications.

However, analysts are likely to remain cautious until stronger orders and utilization rates demonstrate that infrastructure spending is translating into sustained chemical demand.

Implications for Chemical Buyers

The outlook for Evonik and Lanxess is also relevant to chemical procurement teams.

Buyers should monitor:

• Production utilization and plant operating rates

• European chemical demand

• Asian export competition

• Energy and feedstock costs

• Freight and logistics conditions

• Currency movements

• Infrastructure-driven demand

• Potential capacity reductions or restructuring

For buyers, weak demand can create opportunities to negotiate prices, while plant closures or capacity reductions could eventually tighten availability for selected specialty chemicals.

A diversified supplier base will therefore remain important.

What Investors and Market Participants Should Watch

The key question for both companies is whether recent improvements represent the beginning of a sustainable recovery or temporary relief caused by supply disruptions and cost-management measures.

For Evonik, investors will watch whether its stronger performance can support the newly increased 2026 earnings outlook once supply-chain conditions normalize.

For Lanxess, attention will remain on whether cost savings, pricing measures, and German infrastructure spending can offset weak industrial demand and currency pressure.

Both companies will also need to demonstrate that restructuring and efficiency programs can produce lasting improvements rather than simply compensate for short-term market weakness.

Outlook

Germany's chemical sector remains at a crossroads.

There are some encouraging developments, including stronger performance at Evonik and the potential for infrastructure spending to support demand. However, persistent structural challenges—including high energy costs, weak European industrial activity, excess global capacity, and Asian competition—continue to limit confidence in a rapid recovery.

The broader German chemical industry remains vulnerable to further external shocks, while companies must continue adapting their production footprints and cost structures.

Conclusion

Evonik and Lanxess are entering the second half of 2026 with cautious optimism but significant risks.

Evonik has strengthened its 2026 earnings outlook following better-than-expected performance, while Lanxess continues to target improved profitability through cost reductions, pricing actions, and potential recovery in construction-related demand.

Nevertheless, analysts remain cautious because the fundamental problems facing Germany’s chemical industry have not disappeared. Weak demand, expensive energy, Asian competition, geopolitical uncertainty, and low industrial utilization continue to shape the market.

For the companies, the challenge is now to turn temporary improvements into sustainable earnings growth. For chemical buyers, the evolving environment reinforces the importance of monitoring production capacity, supplier economics, and regional trade flows closely.